1. P231 Once-daily Tiotropium Respimat®: Safety And Tolerability Results From Five Phase Iii Trials In Adults With Symptomatic Asthma. (10th November 2014) Authors: Haughney, J; Vandewalker, M; Meltzer, E; Paggiaro, P; Engel, M; Unseld, A; Moroni-Zentgraf, P; Kerstjens, HAM Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗